Pharmaceutical Product Develop (PPDI) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	416.75M
Short-term investments	63.58M
Accounts receivable and unbilled services, net	505.01M
Income tax receivable	17.47M
Investigator advances	13.01M
Prepaid expenses	25.7M
Deferred tax assets	41.33M
Cash held in escrow	2.29M
Other current assets	17.98M
Total current assets	1.1B
Property and equipment, net	404.37M
Goodwill	292.91M
Long-term investments	0
Other investments	77.58M
Intangible assets	28.21M
Other assets	44.77M
Total assets	1.95B
Accounts payable	37.73M
Payables to investigators	65.47M
Accrued income taxes	6.06M
Other accrued expenses	204.94M
Unearned income	337.09M
Total current liabilities	651.28M
Accrued income taxes	34.92M
Accrued pension liability	11.86M
Deferred rent	15.29M
Deferred tax liabilities	28.78M
Other liabilities	8.12M
Total liabilities	750.25M
Redeemable noncontrolling interests	2.13M
Common stock	5.68M
Paid-in capital	619.76M
Retained earnings	583.41M
Accumulated other comprehensive income (loss)	-17.59M
Total shareholders' equity	1.19B
Noncontrolling interests	7.32M
Total equity	1.2B
Total liabilities and equity	1.95B

Entities mentioned with PPDI

View All Entities